REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 74 filers reported holding REPROS THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,486,000 | -13.5% | 200,000 | 0.0% | 0.07% | -1.4% |
| Q1 2015 | $1,718,000 | +7.6% | 200,000 | +116.6% | 0.07% | +19.7% |
| Q2 2014 | $1,596,000 | -38.9% | 92,318 | -37.5% | 0.06% | -54.1% |
| Q1 2014 | $2,613,000 | -76.2% | 147,618 | -75.4% | 0.13% | -73.6% |
| Q4 2013 | $10,982,000 | -35.6% | 600,418 | -5.7% | 0.50% | -39.9% |
| Q3 2013 | $17,056,000 | +29.0% | 636,418 | -11.2% | 0.84% | +7.2% |
| Q2 2013 | $13,218,000 | – | 716,418 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 978,800 | $1,292,000 | 0.33% |
| Allegis Investment Advisors, LLC | 344,487 | $455,000 | 0.14% |
| GENERAL AMERICAN INVESTORS CO INC | 589,768 | $778,000 | 0.08% |
| Acrospire Investment Management LLC | 23,177 | $31,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 268,130 | $354,000 | 0.01% |
| Alambic Investment Management, L.P. | 16,091 | $21,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 51,359 | $68,000 | 0.00% |
| Renaissance Technologies | 716,413 | $946,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $4,000 | 0.00% |
| Virtu KCG Holdings LLC | 45,144 | $60,000 | 0.00% |